Case Report: Splenic Mucormycosis; A Post-Covid Sequelae
DOI:
https://doi.org/10.3126/jaim.v11i1.48195Keywords:
COVID-19, Mucormycosis, Renal transplantation, Amphotericin BAbstract
Introduction: Mucormycosis is an invasive disease associated with high mortality ranging from 25-62%. There is an increase in the incidence of mucormycosis in post COVID-19 infection patients.
Case presentation: A 55 year old male presented to the emergency department with complain of pain abdomen and with a past medical history of renal transplantation and recent COVID-19 infection. On CT abdomen evaluation he was found to have hypodense spleen suggestive of splenic abscess. Investigations and Treatment: Splenectomy was done, which on microbiological examination revealed mucormycosis. The patient was treated with amphotericin B for 3 weeks followed by posaconazole for another 2 weeks.
Discussion: Mucormycosis, although a rare infection, has been classically linked to organ transplantation which can also be considered as a possible reason for immunosuppression in this case. Transplant physicians must be aware that patients with COVID-19 are at risk of developing unusual opportunistic infections.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator.